We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




How Stress Increases Cardiovascular Risk

By Biotechdaily staff writers
Posted on 10 Jun 2002
Researchers have found that mental stress contributes to the risk of cardiac disease by causing changes in the endothelial cells of blood vessels that interfere with their ability to dilate. More...
This serves to restrict the flow of blood, a condition that can increase the risk of a heart attack or stroke.

It is well known that grief, anger, shock or other severely stressful events can cause sudden cardiac death. How this happens at the molecular level was not clear. Now a study published in the May 20, 2002, issue of Circulation describes the biochemical effect of mental stress on blood vessels.

The researchers, from University Hospital (Zurich, Switzerland), studied subjects aged 20-31 years old with no known cardiovascular risk factors. Ultrasound was used in five individuals to assess the ability of their blood vessels to dilate both before and 10 minutes after a three-minute mental stress task. Six subjects had dilation measured before and after the task while being infused with a drug called an ETa (endothelin-A) receptor blocker that causes dilation. For comparison, saline was infused in a control group of three people. For the mental stress task, subjects had to respond as quickly as possible to colored lights by pushing a button of the corresponding color. Researchers found a significant decrease in blood-vessel dilation after mental stress. The mental stress test increased average arterial blood pressure from 83-96 millimeters of mercury (mm Hg) and heart rate from 63-81 beats per minute. Flow-mediated dilation was reduced by half, from 8.0 to 4.1.

Administration of the ETa receptor blocker prevented this significant drop in dilation capability (8.6 before vs. 9.4 at 10 minutes after). The investigators believe this response identifies ETa activation as a mechanism responsible for endothelial dysfunction; therefore, blocking ETa receptors may be a novel way to prevent atherosclerosis.

"Endothelial dysfunction induced by mental stress offers a novel and unique link between psychological factors and the cause of atherosclerosis, similar to other risk factors that impair function such as high cholesterol or high blood pressure,” explained Dr. Georg Noll.



Related Links:
University Hospital (Zurich)

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.